HOME >> BIOLOGY >> NEWS
Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease

Blacksburg, Va., June 10, 2004 Virginia Bioinformatics Researcher Brett Tyler and his colleagues are one step closer to finding a cure for a disease affecting California oak trees that is now showing up in nurseries in a dozen states, including Virginia, and threatening woody ornamentals and East Coast forests.

Tyler and his colleagues have successfully mapped the genome of the devastating pathogens Phytophtora sojae and Phytophtora ramorum. P. ramorum, also known as sudden oak death, is a serious fungal pathogen that has attacked and killed tens of thousands of California and Oregon oak trees. P. sojae, the sister pathogen to P. ramorum, causes serious damage to soybean crops and cost growers $1 billion worldwide last year.

The sequences of P. sojae will act as a "Rosetta Stone" to help researchers better understand P. ramorum's genome makeup and uncover valuable information to help cure and prevent sudden oak death disease. In addition, the sequencing of the P. ramorum genome represents the fastest tracking time between the identification of a complex pathogen (in 2000) and the completion of its genome (in 2004).

Tyler, along with representatives from the Department of Energy Joint Genome Institute (JGI at www.jgi.doe.gov), United States Department of Agriculture (USDA), USDA Forest Service, the National Science Foundation (NSF) and others will present the scientific findings to the media on June 10, 2004 at the Joint Genome Institute in Walnut Creek, California.

Sudden oak death disease has the potential to affect forests in the Appalachian highlands in Virginia and other areas on the East Coast. The disease kills the oak tree, but usually the carrier shrubs survive. Sudden oak death has affected California redwood seedlings and sprouts, but not the trunks. However, it poses a large threat to Virginia oak trees and other Eastern Seaboard plant species that have proven highly susceptible to the pathogen in greenhouse tests. Tyler i
'"/>

Contact: Blanche O'Neill
oneill@vbi.vt.edu
540-231-1976
Virginia Tech
10-Jun-2004


Page: 1 2

Related biology news :

1. Two Virginia Tech energy-related inventions win R&D 100 awards
2. Virginia Tech researchers to release findings on Smith River Project
3. Virginia Tech professor honored with DeLaval Award
4. Virginia Techs smelly corpse plant due to bloom Aug. 4
5. Virginia Center for Coal and Energy Research helps implement global climate change initiative
6. Cell cycle research earns biologist Virginias top scientist award
7. Virginia Tech-led group receives third five-year international biodiversity grant
8. Virginia Tech researcher receives $1.8 million to study Arabidopsis genome
9. Virginia Tech and North Carolina State University to run Forest Nutrition Research Cooperative
10. Virginia Bioinformatics Institute central to Regional Center of Excellence
11. NIH awards $1 million to Virginia Bioinformatics Institute to study biochemical network modeling

Post Your Comments:
(Date:2/5/2015)... 26, 2015   Epic Sciences , a precision diagnostics ... that Murali Prahalad , Ph.D., president and CEO, is ... (PMWC) 2015: Silicon Valley, which is taking place at ... on January 26-28, 2015. Dr. ... as Biomarkers." Last year, Epic Sciences was a finalist in ...
(Date:2/5/2015)... IRVINE, Calif. , Jan. 27, 2015 ... trusted provider of globally deployed, innovative test ... today announced the delivery of its ... Martin Space Systems Company (LMSSC). GENASYS is ... the demands of mission-critical applications that require ...
(Date:2/5/2015)... , Jan. 28, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... upcoming RedChip Global Online CEO Conference on January 29 ... Gino Pereira , CEO of NXT-ID will present ... product, the Wocket smart wallet and its full suite ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
(Date:3/5/2015)... TORONTO , March 5, 2015 /PRNewswire/ - Aptose ... developing new therapeutics and molecular diagnostics that target the ... G. Rice , Ph.D., Chairman, President and Chief Executive ... Conference on Tuesday, March 10 th at 9:30 ... Laguna Niguel, CA. Dr. Rice will provide ...
(Date:3/5/2015)... 05, 2015 The next implants made ... the CE mark (European) approval. The CE mark is ... Association (EFTA) and the European Union. Following the Class ... granted to implants supplied by the Turkey-based company Osimplant ... , Osimplant's Cervical Expandable Bladed HA PEEK Cage line ...
(Date:3/4/2015)... 2015  Brooklyn residents now have a new place ... and injuries. Nunzio Saulle , M.D., a board-certified ... his NJS Physical Medicine and Rehabilitation (PM&R) practice in ... 5, 2015. Health Plus Management, LLC is managing the ... 1178 Flatbush Avenue. This new PM&R practice will treat ...
(Date:3/4/2015)... CA. (PRWEB) March 04, 2015 ... headquartered in the San Francisco Bay Area, will exhibit ... (OCT) Israel Conference 2015 on March 25th and ... seeks to build relationships with Israeli life science companies ... clinical trials. The company’s services span all phases of ...
Breaking Biology Technology:Aptose Biosciences to Present at the 27th Annual ROTH Conference 2Aptose Biosciences to Present at the 27th Annual ROTH Conference 3Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3NJS Physical Medicine & Rehabilitation Opening on Flatbush Avenue, Brooklyn, NY 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4
Cached News: